Location History:
- Baldock, GB (1981 - 1986)
- Barley, GB (1994 - 1995)
- Royston, GB (1989 - 2005)
Company Filing History:
Years Active: 1981-2005
Title: Michael John Broadhurst: A Pioneer in Pharmaceutical Innovations
Introduction: Michael John Broadhurst, based in Royston, Great Britain, is a distinguished inventor renowned for his contributions to the field of pharmaceuticals. With an impressive portfolio of 23 patents, Broadhurst has demonstrated a steadfast commitment to innovation and research, significantly impacting the treatment of various diseases.
Latest Patents: Among his latest innovations are the "Oxamide IMPDH inhibitors," which focus on compounds that are oxamide derivatives, serving as inhibitors of the enzyme inosine monophosphate dehydrogenase (IMPDH). Additionally, he has developed "Cyclic hydrazine derivatives," which encompass hydrazine derivatives and their pharmaceutically acceptable salts, aimed at treating inflammatory and autoimmune diseases, osteoarthritis, respiratory diseases, tumors, cachexia, cardiovascular disease, fever, hemorrhage, and sepsis.
Career Highlights: Michael John Broadhurst is currently employed at Hoffmann-La Roche Inc., a leading company in the biopharmaceutical sector. His extensive work at the company has allowed him to contribute to significant advancements in drug development and therapeutic treatments through his innovative patents.
Collaborations: Throughout his career, Broadhurst has collaborated with notable professionals, including William H. Johnson and Paul Anthony Brown. These collaborations have fostered an environment of creative problem-solving and shared knowledge, propelling their work to greater heights.
Conclusion: Michael John Broadhurst stands out as a prominent figure in the pharmaceutical industry with his significant inventions and patents. His continued efforts in research and development showcase his dedication to improving patient care and advancing medical science.